Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Trading Up 9.4% – Time to Buy?

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) traded up 9.4% on Tuesday . The stock traded as high as $24.1750 and last traded at $24.1750. 2,000 shares changed hands during mid-day trading, a decline of 42% from the average session volume of 3,470 shares. The stock had previously closed at $22.10.

Wall Street Analyst Weigh In

Separately, Royal Bank Of Canada upgraded Fisher & Paykel Healthcare to a “sector perform” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.

Fisher & Paykel Healthcare Stock Up 9.4%

The firm has a fifty day simple moving average of $21.76 and a two-hundred day simple moving average of $21.16.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.

The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.